SRAVNITEL'NAYa OTsENKA EFFEKTIVNOSTI DEYSTVIYa RAZLIChNYKh DOZ STATINOV NA OChAGI ENDOMETRIOZA PRI EGO EKSPERIMENTAL'NOY MODELI


Cite item

Full Text

Abstract

References

  1. Адамян Л.В., Кулаков В.И., Андреева Е.Н. Эндометриозы. - М.: «Медицина», 2006.
  2. Aarons C.B., Cohen P.A., Gower A. et al. Statins (HMG-CoA reductase inhibitors) decrease postoperative adhesions by increasing peritoneal fibrinolytic activity // Ann. Surg. - 2007. - Vol. 245, № 2. - P. 185-186.
  3. Amsterdam L.L., Gentry W., Jobanputra S.et al., Wolf M, Rubin SD and Bulun SE. Anastrazole and oral contraceptives: a novel treatment for endometriosis // Fertil. and Steril. - 2005. - Vol. 84, № N 2. - P. 300-304.
  4. Bruner-Tran K.L., Osteen K.G., Duleba A.J. Simvastatin protects against the development of endometriosis in a nude mouse model // J. Clin. Endocrinol. Metab. - 2009. - Vol.94, № 7. - P. 2489-2494.
  5. Folkman J. Seminars in Medicine of the Beth Israel Hospital, Boston. Clinical applications of research on angiogenesis // N. Engl. J. Med. - 1995. - Vol. 333, № 26. - P. 1757-1763.
  6. Gazvani R., Templeton A. Peritoneal environment, cytokines and angiogenesis in the pathophysiology of endometriosis // Reproduction. - 2002. - Vol. 123, № 2. - P. 217-226.
  7. Halme J., White C., Kauma S. et al., Estes J, Haskill S. Peritoneal macrophages from patients with endometriosis release growth factor activity in vitro // J. Clin. Endocrinol. Metab. - 1988. - Vol. 66, № 5. - P.1044-1049.
  8. James K. Liao Isoprenoids as mediators of the biological effects of statins // J. Clin. Invest. - 2002. - Vol. 110, № 3. - P. 285-288.
  9. KinselL.B., Szabo E., Greene G.L. et al., Konrath J, Leight GS, McCarty KS Jr. Immunocytochemical analysis of estrogen receptors as a predictor of prognosis in breast cancer patients: comparison with quantitative biochemical methods // Cancer Res. - 1989. - Vol. 49, № 4. - P.1052-1060.
  10. LaRosa J.C., Grundy S.M., Waters D.D., Shear C, Barter P, Fruchart JC, Gotto AM,Greten H, Kastelein JJ, Shepherd J, et al. Intensive lipid lowering with atorvastatin in patients with stable coronary disease // N. Engl. J . Med. - 2005. - Vol. 352, № 14. - P.1425-1435.
  11. Maas J.W., Le Noble F.A., Dunselman G.A., de Goeij AF, et al. Struyker Boudier HA and Evers JL The chick embryo chorioallantoic membrane as a model to investigate the angiogenic properties of human endometrium // Gynecol. Obstet. Invest. - 1999. - Vol.48, № 2. - P.108-112.
  12. Na Y.J., Jin J.O., Lee M.S. et al., Song MG, Lee KS, Kwak JY. Peritoneal fluid from endometriosis patients switches differentiation of monocytes from dendritic cells to macrophages // J. Reprod. Immunol. - 2008. - Vol.77, № 1. - P.63-74.
  13. NavidEsfandiari, D.V.M., Ph.D., MozafarKhazaei, Ph.D., Jafar Ai et al., Ph.D.,Ryszard Bielecki, D. V.M., Lynda Gotlieb, R.N., Edward Ryan, M.B., B.Ch.,and Robert F. Casper, M.D. Effect of a statin on an in vitro model of endometriosis // Fertil. and Steril. - 2007. - Vol.87, № 2. - P. 257-262.
  14. Oktem M., Esinler I., Eroglu D. et al., Haberal N, Bayraktar N, Zeyneloglu HB. High-dose atorvastatin causes regression of endometriotic implants: a rat model // Hum. Reprod. - 2007. - Vol. 22, № 5. - P.1474-1480.
  15. Oral E., Seli E., Bahtiyar M.O. et al., Olive DL, Arici A. Growth-regulated alpha expression in the peritoneal environment with endometriosis // Obstet. Gynecol. - 1996. - Vol.88, № 6. - P. 1050- 1060.
  16. Piotrowski P.C., Kwintkiewicz J., Rzepczynska I.J. et al., Seval Y, Cakmak H, Arici A, Duleba AJ. Statins inhibit growth of human endometrial stromal cells independently of cholesterol availability // Biol. Reprod. - 2006. - Vol. 75, № 1. - P. 107-111.
  17. Risau W. Mechanisms of angiogenesis // Nature. - 1997. - Vol.386, № (6626). - P. 671-674.
  18. Rutishauser J. The role of statins in clinical medicine- LDL-cholesterol lowering and beyond // Swiss. Med. Wkly. - 2006. - Vol.136. - P. 41-49.
  19. Sampson J.A. Metastatic or Embolic Endometriosis, due to the Menstrual Dissemination of Endometrial Tissue into the Venous Circulation // Am. J. Pathol. - 1927- Vol.3, № N2. - P. 93-110.43
  20. Skaletz-Rorowski A., Walsh K. Statin therapy and angiogenesis // Curr. Opin. Lipidol. - 2003. - Vol. 14, № 6. - P. 599-603.
  21. Strathy J.H., Molgaard C.A., Coulam C.B., et alMelton LJ. Endometriosis and infertility-a laparoscopic study of endometriosis among fertile and infertile women // Fertil. and Steril. - 1982. - Vol. 38. - P. 667-672.
  22. Taylor R.N., Lebovic D. I., Mueller M.D. Angiogenic factors in endometriosis // Ann. N. Y. Acad. Sci. - 2002. - Vol. 955. - P.89-100.
  23. Vernon M.W., Wilson E.A.: Studies on the surgical induction of endometriosis in the rat // Fertil. and Steril. - 1985. - Vol. 44, № 5. - P.684-694.
  24. Wheeler J.M.: Epidemiology and prevalence of endometriosis // Infertil. Reprod. Med. Clin. North. Am. - 1992. -№ N 3. - P. 545-549.
  25. Yancopoulos G.D., DavisS., GaleN.W., et al. Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation // Nature. - 2000. - Vol. 407. № (6801). - P. 242-248.

Supplementary files

Supplementary Files
Action
1. JATS XML
Download

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies